Like most American cities, San Diego’s planning choices hold a gruesome legacy. Why are we okay with that? On October 20th, ...
THE COMPANY EXPECTS TO RELEASE TOPLINE RESULTS FOR SKNJCT-003 PHASE 2 CLINICAL TRIAL BEFORE THE END OF Q1 2026 AND REQUEST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback